Pacific Edge outlines Plan B at annual meeting

Pacific Edge outlines Plan B at annual meeting
Pacific Edge still awaits a decision about Medicare. (Image: Pacific Edge)
Victoria Young
It was standing room only for investors pressing cancer diagnostics firm Pacific Edge’s board and management about its wider plans at the firm’s AGM in Auckland on Tuesday. At least 70 shareholders were keen on more details about pending Medicare coverage for the Dunedin-headquartered firm. Chief executive Peter Meintjes told investors the company is in a “head-down, bum-up situation" as it awaits a decision from the US about access to the Medicare system from Novitas, the Medicare Administrative Contractor (MAC...

More Markets

Fletcher’s down 3.6%; NZX misses ceasefire rally
Markets Market Close

Fletcher’s down 3.6%; NZX misses ceasefire rally

 Channel Infrastructure has benefited from tensions in the Middle East, an analyst said.

Fletcher's restructuring, impairment costs could hit $781m
Infrastructure

Fletcher's restructuring, impairment costs could hit $781m

It expects ebit of $370m to $375m before significant items. 

Selling Kiwifruit at Beijing’s $5b-a-year department store
Primary Sector

Selling Kiwifruit at Beijing’s $5b-a-year department store

Turns out the personal touch helps sell kiwifruit at a high-end Chinese supermarket.

Tait wants Vital to fast-track growth
Markets

Tait wants Vital to fast-track growth

If successful, Tait Communications will pay $18.7m to take the listed firm private.